Publication

研究業績

2012年

  1. D. Iohara, K. Yoshida, K. Yamaguchi, M. Anraku, K. Motoyama, H. Arima, K. Uekama and F. Hirayama,
    Cyclodextrin-induced Change in Crystal Habit of Acetylsalicylic Acid in Aqueous Solution,
    Cryst. Growth Des., 12(4), 1985-1991 (2012).
  2. M. Anraku, H. Tomida, A. Michihara, D. Tsuchiya, D. Iohara, Y. Maezaki, K. Uekama, T. Maruyama, M. Otagiri and F. Hirayama,
    Antioxidant and Renoprotective Activity of Chitosan in Nephrectomized Rats,
    Carbohydr. Polym., 89, 302-304 (2012).
  3. H. Arima, M. Arizono, T. Higashi, A. Yoshimatsu, H. Ikeda, K. Motoyama, K. Hattori, T. Takeuchi, F. Hirayama and K. Uekama,
    Potential Use of Folate-polyethylene glycol (PEG)-Appended Dendrimer (G3) Conjugate with a-Cyclodextrin as DNA Carriers to Tumor Cells,
    Cancer Gene Ther., 19(5), 358-366 (2012).
  4. T. Anno, T. Higashi, K. Motoyama, F. Hirayama, K. Uekama and H. Arima,
    Possible Enhancing Mechanisms for Gene Transfer Activity of Glucuronylglucosyl-β-cyclodextrin/dendrimer Conjugate (G2),
    Int. J. Pharm., 426(1-2), 239-247 (2012).
  5. D. Iohara, M. Hiratsuka, F. Hirayama, K. Takeshita, K. Motoyama, H. Arima and K. Uekama,
    Evaluation of photodynamic activity of C60/2-hydroxypropyl-β-cyclodextrin nanoparticles,
    J. Pharm. Sci.,101(9), 3390-3397 (2012).
  6. T. Anno, T. Higashi, K. Motoyama, F. Hirayama, K. Uekama and H. Arima ,
    Potential use of glucuronylglucosyl-β-cyclodextrin/dendrimer conjugate (G2) as a DNA carrier in vitro and in vivo,
    J. Drug Target., 20(3), 272-280 (2012).
  7. K. Uehata, T. Anno, K. Hayashida, T. Higashi, K. Motoyama, F. Hirayama, K. Uekama and H. Arima,
    Peak-less Hypoglycemic Effect of Insulin Glargine by Complexation with Maltosyl-β-cyclodextrin,
    Int. J. Pharm., 422(1-2), 33-39 (2012).
  8. 本山敬一、東 大志、平山文俊、上釜兼人、有馬英俊
    シクロデキストリンポリシュードロタキサンを用いたタンパク質・遺伝子徐放システム,
    PHARM TECH JAPAN,28(10), 169-177 (2012).